ArticleCrohn's & colitis 3602022

Adalimumab Is Associated With Lower Healthcare Resource and Steroid Use Versus Vedolizumab in Biologic-Naive Crohn's Disease: A Retrospective Claims Database Analysis.

Ryan C Ungaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.